Unexpected findings add new insight on cannabis and heart health
Peer-Reviewed Publication
Updates every hour. Last Updated: 25-Oct-2026 16:15 ET (25-Oct-2026 20:15 GMT/UTC)
Habitual cannabis users experienced about 9% fewer premature heartbeats on days they inhaled cannabis compared with days they abstained, a counterintuitive finding that adds to the complex and evolving understanding of how cannabis affects the heart, new UC San Francisco-led research found.
Generative AI gives health experts the ability to create realistic synthetic genetic data that helps to identify behaviour of disease complications.
Researchers have found that pediatric-onset rheumatic and inflammatory diseases have distinct genetic architecture compared with adults. The findings could pave the way for the discoveries that have benefitted adult patients with similar conditions, like better disease classification and the development of precision therapies.
What if one of the keys to a healthier metabolism is understanding how and when the liver communicates with the rest of the body?
Researchers at UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), have uncovered how the liver’s internal clock coordinates the release of proteins that help regulate metabolism.
New research finds that men who consume higher amounts of ultra-processed foods (UPFs) have significantly greater risks of prostate cancer. Analyzing nationally representative data from 17,024 U.S. men, researchers found a 29% higher risk among those in the three highest UPF-consumption groups and a 30% higher risk among those in the two highest groups. After adjusting for key factors, elevated risk remained significant, ranging from 24% to 31%.
A Case Western Reserve University–led research team is developing a noninvasive oral cancer test to help clinicians decide—chairside and within minutes— whether a suspicious lesion in the mouth needs a biopsy.
CAMBRIDGE, Mass., Aug 12 — Insilico Medicine (“Insilico”; HKEX: 3696), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced the nomination of ISM0900, a potent, AI-driven, highly selective, orally available small molecule inhibitor of lipoprotein(a), or Lp(a), as a preclinical candidate (PCC) for the management of cardiovascular risks. Notably, this marks the company's 9th PCC nomination announced since 2026, showcasing the enhanced efficiency and scalability that generative AI brings to early-stage drug discovery.
A new commentary published in a special issue of the American Journal of Public Health argues that the current application process for public assistance programs such as SNAP and Medicaid creates “a lose-lose scenario," as eligible applicants often abandon the time-consuming applications out of frustration and miss out on opportunities to improve their health, which defeats the purpose of these services.
Ribosomes, the protein factories of our cells, have difficulties building large proteins residing in cellular membranes, a new study finds / publication in The EMBO Journal